Switzerland

 

Has the RAD-x sale stalled?

The sale process for pan-European radiology group RAD-x may have stalled, with no statements on progress from any of the parties involved. A well-placed German imaging operator tells HBI that the sale will no longer go ahead, while the group itself is giving nothing away.
January 26, 2023

Sanoptis targets Spain for expansion

Sanoptis, Germany’s second largest ophthalmology group by revenue, is looking to expand in Spain, and beyond, and looking at targets to buy.
January 13, 2023

EDG sale “in early stages”

HBI understands that the sale of pan-European and dentist-led European Dental Group (EDG) has begun, and is in its very early stages. 
November 18, 2022

Swiss Medical Network subsidiary to become country’s first payor-provider

Hôpital du Jura Bernois, a subsidiary of Switzerland's second largest hospital group Swiss Medical Network, is to become the country's first integrated payor-provider, after health insurer Visana bought a 32.4% stake. From January 1 2023 it will offer insurance alongside its hospital and outpatient services to inhabitants of the Jura Arc region.
October 28, 2022

EDG for sale, while Dentex sells

As exclusively predicted by HBI at the start of August, pan-European and dentist-led European Dental Group (EDG) is up for sale.
September 16, 2022

European Dental Group “up for sale soon”

HBI hears that pan-European and dentist-led European Dental Group (EDG) could be up for sale soon. HBI takes a look at the business and possible pricing at a time when dentistry continues to be a hot ticket.
August 5, 2022

Mediclinic accepts £3.7bn bid

The board of Mediclinic, the South Africa-based multinational hospital giant, have announced they have agreed acquisition terms with the consortium comprised of Remgro, the investment vehicle of the billionaire Rupert family and a long-time Mediclinic shareholder, and the Mediterranean Shipping Company (MSC). They have recommended these terms to shareholders.
August 5, 2022

Bid may undervalue Mediclinic

South African analysts say the 504p per share, £3.7bn proposed cash offer for Mediclinic International's equity, the South African, Swiss and Middle East hospital group may somewhat undervalue the business. The current offer equates to an enterprise value of £5.88bn. Analysts put the break up value on an enterprise value at between £5.5bn and £6.2bn. HBI reckons the equity alone could be worth £5.2bn.
July 20, 2022

3R buys in Switzerland and looks at France

Naxicap-owned imaging group 3R Réseau Radiologique Romand has bought IRIS Radiologie and is eyeing up France. Germany and Italy are also possibles, HBI hears.
July 7, 2022
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us